- Highlighted Item:
- Webinar:
- Publisher:Pharmaceutical Technology
- Publication Date:MAR 2021
- Reference:
- DOI:
- PMID:
- Publication Type:Other
- Scientific Area:
- Endpoint:
- Carcinogenicity
- Mutagenicity
- Industry Type:
Managing the risk of nitrosamine impurities
Scientists from IQ, in collaboration with Lhasa Limited and Leadscope Inc. (part of Instem), recruited a network with expertise in genetic toxicology, pathology, computational toxicology and risk assessment toxicology to better evaluate the safety aspects of NAs.